Barclays’s Ventyx Biosciences VTYX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $225K | Buy |
105,397
+44,034
| +72% | +$94K | ﹤0.01% | 3456 |
|
|
2025
Q1 | $70K | Sell |
61,363
-30,306
| -33% | -$34.6K | ﹤0.01% | 3798 |
|
|
2024
Q4 | $200K | Buy |
91,669
+11,374
| +14% | +$24.8K | ﹤0.01% | 3518 |
|
|
2024
Q3 | $175K | Buy |
80,295
+58,776
| +273% | +$128K | ﹤0.01% | 3543 |
|
|
2024
Q2 | $51K | Sell |
21,519
-11,487
| -35% | -$27.2K | ﹤0.01% | 3677 |
|
|
2024
Q1 | $181K | Sell |
33,006
-40,258
| -55% | -$221K | ﹤0.01% | 3387 |
|
|
2023
Q4 | $181K | Sell |
73,264
-154,956
| -68% | -$383K | ﹤0.01% | 3545 |
|
|
2023
Q3 | $7.93M | Buy |
228,220
+204,762
| +873% | +$7.11M | ﹤0.01% | 950 |
|
|
2023
Q2 | $769K | Buy |
23,458
+5,954
| +34% | +$195K | ﹤0.01% | 2333 |
|
|
2023
Q1 | $586K | Buy |
17,504
+6,669
| +62% | +$223K | ﹤0.01% | 2535 |
|
|
2022
Q4 | $355K | Buy |
10,835
+7,787
| +255% | +$255K | ﹤0.01% | 2794 |
|
|
2022
Q3 | $106K | Sell |
3,048
-275,335
| -99% | -$9.58M | ﹤0.01% | 3404 |
|
|
2022
Q2 | $3.41M | Sell |
278,383
-10,657
| -4% | -$130K | ﹤0.01% | 1277 |
|
|
2022
Q1 | $3.92M | Buy |
+289,040
| New | +$3.92M | ﹤0.01% | 1306 |
|